ImmuCell Corporation Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- ImmuCell Corporation stock issued during period, value, new issues for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- ImmuCell Corporation stock issued during period, value, new issues for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- ImmuCell Corporation stock issued during period, value, new issues for the quarter ending 2025-06-30 was $304.99K, a 20.67% increase year-over-year.
- ImmuCell Corporation stock issued during period, value, new issues for the quarter ending 2025-03-31 was -$23.54K.
- ImmuCell Corporation stock issued during period, value, new issues for fiscal 2025 was $281.45K, a 93.54% decline from fiscal 2024.
- ImmuCell Corporation stock issued during period, value, new issues for fiscal 2024 was $4.36M.
- ImmuCell Corporation stock issued during period, value, new issues for fiscal 2021 was $4.23M.
- ImmuCell Corporation stock issued during period, value, new issues for fiscal 2019 was $8.30M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $281.45K 10-K · filed 2026-03-30 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $804.54K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $304.99K 10-Q · filed 2026-08-13 | $4.38M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | -$23.54K 10-Q · filed 2026-05-14 | $4.33M derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $523.10K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $4.36M 10-K · filed 2026-03-30 |
| 2024-09-30 | $3.58M 10-Q · filed 2025-11-13 | |
| 2024-06-30 | $252.75K 10-Q · filed 2024-08-13 | |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | $4.23M 10-K · filed 2023-03-29 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q/A 6 month · filed 2022-11-21 | |
| 2021-06-30 | $4.23M 10-Q/A · filed 2022-11-21 | |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | $8.30M 10-K · filed 2021-03-30 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12 | |
| 2019-03-31 | $8.30M 10-Q · filed 2020-05-13 | |
| 2017-12-31 | $2.73M 10-K · filed 2019-03-22 | |
| 2016-12-31 | $5.31M 10-K · filed 2018-03-29 | |
| 2016-03-31 | $5.31M 10-Q · filed 2016-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |